2-aminoethyl substituted pyrimidin2-ones, cyclopropanes, pyrazolines, pyrimidines and benzothiazepines and their use as urotensin II and somatostatin 5 receptor ligands

Details for Australian Patent Application No. 2004213000 (hide)

Owner Acadia Pharmaceuticals Inc.

Inventors Olsson, Roger

Agent Griffith Hack

Pub. Number AU-A-2004213000

PCT Pub. Number WO2004/073642

Priority 60/448,629 19.02.03 US

Filing date 18 February 2004

Wipo publication date 2 September 2004

International Classifications

C07D 239/22 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

1 September 2005 PCT application entered the National Phase

  PCT publication WO2004/073642 Priority application(s): WO2004/073642

21 February 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004213006-Methods and devices for draining fluids and lowering intraocular pressure

2004212997-Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy